The surgical technology developer was valued at $3bn in a series C round backed by returning investor Cambridge Innovation Capital.

CMR Surgical, a UK-based surgical robotics technology developer, has raised $600m in a series D round backed by Cambridge Innovation Capital (CIC).
The round, which valued CMR at $3bn, was co-led by telecoms group SoftBank’s Vision Fund 2 and healthcare investment group Ally Bridge.
GE Healthcare, a subsidiary of power and industrial technology conglomerate General Electric, also took part, as did internet company Tencent, RPMI Railpen, Chimera, LGT and its Lightrock affiliate, Watrium and PFM Health Sciences.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?